For Lung Cancer Awareness Month Biodesix created an infographic to help explain the problem of lung nodules and how physicians take care of them.
We are committed to supporting patients and health care providers during the COVID-19 pandemic. Biodesix will continue lab operations without disruption to provide diagnostic testing for patients with, or at risk for lung cancer.
Case study on Longitudinal Monitoring for the Emergence of EGFR C797S resistance mutations in NSCLC using blood-based Droplet Digital PCR.
The VeriStrat® proteomic test was designed using mass spectrometry combined with our proprietary artificial intelligence platform. View case study!
Biodesix is monitoring the COVID-19 news, including all recommendations from our local, state, and federal health agencies. The world is grappling with an issue of enormous scale and human impact, and our hearts go out to all who have been affected by the outbreak of COVID-19.
Physicians discuss how the Nodify XL2 test is helping identify benign pulmonary nodules and relieve patient anxiety. Watch the video now!
Dr. Susan Garwood and Tresia Michael of Tri-Star Health discuss how they use the Nodify XL2 test in their clinic. Watch and learn about lung nodule management.
Dr. Susan Garwood and Tresia Michael, LPN of TriStar Health discuss how the Nodify XL2 test is relieving patient anxiety in their lung nodule clinic.